SCHEMBL7552008

SCHEMBL7552008

COc1ccc(S(=O)(=O)N(CC(=O)NO)CC(=O)N(C)C)cc1

nearest known ligand 0.72

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
BMP1 P13497 3/20 0.72
MMP1 P03956 6/20 0.71
MMP8 P22894 6/20 0.71
MMP13 P45452 6/20 0.71
MMP7 P09237 2/20 0.71
MMP12 P39900 2/20 0.71
MEP1B Q16820 4/20 0.70
MMP3 P08254 8/20 0.63
MMP2 P08253 5/20 0.61
MMP9 P14780 5/20 0.61
MMP14 P50281 3/20 0.61
CA2 P00918 2/20 0.61
MMP16 P51512 2/20 0.61
CA1 P00915 1/20 0.61
CA9 Q16790 1/20 0.61
ADAM10 O14672 1/20 0.58
ADAM17 P78536 1/20 0.58
MEP1A Q16819 1/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8001734 0.87 MEP1B (0.81) BMP1MMP1MMP8MMP13MMP7
SCHEMBL7109267 0.84 BMP1 (1.00) BMP1MMP1MMP8MMP13MMP7
SCHEMBL7348906 0.83 MEP1B (0.86) BMP1MMP1MMP8MMP13MMP7
SCHEMBL26776688 0.83 MMP1 (0.81) BMP1MMP1MMP8MMP13MMP7
SCHEMBL598146 0.83 MMP3 (0.79) BMP1MMP1MMP8MMP13MMP7
SCHEMBL26776708 0.82 MMP1 (0.79) BMP1MMP1MMP8MMP13MMP7
SCHEMBL7342151 0.81 MMP1 (0.70) BMP1MMP1MMP8MMP13MMP7
SCHEMBL26776651 0.81 MMP13 (0.74) BMP1MMP1MMP8MMP13MMP7
SCHEMBL6415304 0.81 BMP1 (0.89) BMP1MMP1MMP8MMP13MMP7
SCHEMBL6418955 0.80 MMP1 (0.76) BMP1MMP1MMP8MMP13MMP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6380219-B1 FOR THERAPY OF ARTHRITIS, CANCER, TISSUE ULCERATION, RESTENOSIS, PERIDONTAL DISEASE, EPIDERMOLYSIS BULLOSA, SCLERITIS AND OTHER DISEASES CHARACTERIZED BY MATRIX METALLOPROTEINASE ACTIVITY, SEPSIS, SEPTIC SHOCK PFIZER INC 2002-04-30 US disclosed
EP-0813520-B1 ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES PFIZER (US) 2001-12-19 EP disclosed
US-6147074-A Arylsulfonylamino hydroxamic acid derivatives PFIZER INC (US) 2000-11-14 US disclosed
US-5994351-A Arylsulfonylamino hydroxamic acid derivatives PFIZER INC. (US) 1999-11-30 US disclosed
US-5863949-A Arylsulfonylamino hydroxamic acid derivatives PFIZER INC (US) 1999-01-26 US disclosed
WO-1996027583-A1 ARYLSULFONYLAMINO HYDROXAMIC ACID DERIVATIVES PFIZER INC. (US) 1996-09-12 WO disclosed